Navigation Links
Producing Vaccines from genetically modified crops

The consortium, called Pharma-Planta, wants to produce vaccines and other treatments for major //diseases, such as HIV/Aids, rabies and TB and they hope to start clinical trials by the year 2009. The project's aim is to focus on areas that will be of greatest benefit to developing nations where they feel that access to most vaccines is very poor at the same time keeping in mind that human health and the environment are protected.

The first product, possibly grown in maize, is likely to be an antibody that can be used to block HIV transmission and it has been decided to incorporate it into a microbicidal cream that could be used in the vagina. The second product will probably to be a post-bite vaccine for rabies, which is still a significant killer in Africa and southeast Asia.

Researchers at Pharma –Planta say that the plants will be grown in pharmaceutical production units on dedicated land , isolated from food crops. Thirty-nine labs in 11 European countries will work together, with input from researchers in South Africa, where HIV/Aids is a major public health issue. Scientific co-ordinators at Pharma –Planta say many commercial companies have withdrawn from vaccine development and production because of low economic returns ,however they say that Pharma-Planta hopes the technology it will develop over the course of its initial five years of funding will eventually boost the global supply of treatments.

Current methods used include genetic modification of human cells and microorganisms such as bacteria. These techniques are labour intensive, expensive and often only produce relatively small amounts of pharmaceuticals. Researchers at Pharma – Planta say that plants are inexpensive to grow as well as to engineer them to contain a gene for a pharmaceutical product and most importantly they could produce large quantities of drugs or vaccines at low cost. The project has yet to decide which plants to use but some of the plants mos t likely to be used include tobacco, maize, potatoes and tomatoes. Although Pharma- Planta claims to maintain and follow the ideal conditions and procedures for their project others are of the opinion that Pharma- Planta’s research could have widespread negative impacts and also suggest that a clear set of criteria must be established to ensure that human health and the environment are protected

'"/>




Related medicine news :

1. A New study Throws Light On The Growth & Functions Of Insulin Producing Beta Cells
2. New Technique Developed By Scientists For Producing Stem Cells without Damaging Embryos
3. Producing More Drugs For Lethal Diseases Is Not The Answer
4. A Combined Research for Producing Chlamydia Vaccine Begins
5. Height of Liberation – Lesbians, No Less in Producing Babies (read Daughters
6. Understanding Chronic Infections May Help in Developing Therapeutic Vaccines
7. New Anthrax Vaccines Will Take time
8. Success Of Preventable High-Risk HPV Infections With Vaccines May Vary
9. Health and Human Services stockpiles 20 million bird flu Vaccines
10. Chiron Corporation Gets US Contract To Produce Bird Flu Vaccines
11. Oral Edible vaccine for Allergy Vaccines
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, ... at his family verbally and physically. , “When something upset him, he couldn’t control his ... it. He would throw rocks at my other children and say he was going to ...
(Date:6/24/2016)... Diego, CA (PRWEB) , ... June 24, 2016 , ... ... with the American Cancer Society and the Road To Recovery® program to drive cancer ... to seniors and other adults to ensure the highest quality of life and ongoing ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and the ... in the world, and the most handsome men, look naturally attractive. Plastic surgery ...
(Date:6/24/2016)... ... ... Venture Construction Group (VCG) sponsors Luke’s Wings 5th Annual ... Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. The event raised funds ... been wounded in battle and their families. Venture Construction Group is a 2016 Silver ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... CLEMENTE, Calif. , June 24, 2016  American Respiratory Labs ... company, is now able to perform sophisticated lung assessments in patients, ... Technologies , Inc. Patients are no longer limited ... ndd,s EasyOne PRO ® , ARL patients like Jeanne R. of ... done in the comfort of her own home. ...
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
(Date:6/23/2016)... -- MedSource announced today that it has selected Datatrial,s ... choice.  This latest decision demonstrates MedSource,s commitment to ... by offering a state-of-the-art electronic data capture (EDC) ... the EDC platform of choice in exchange for ... long been a preferred EDC platform by our ...
Breaking Medicine Technology: